HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David Oscier Selected Research
David Oscier Research Topics
Disease
25
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2022 - 02/2003
8
Neoplasms (Cancer)
03/2017 - 02/2003
6
Disease Progression
12/2019 - 02/2003
4
Lymphoma (Lymphomas)
01/2019 - 11/2015
2
Chromosome Aberrations (Chromosome Abnormalities)
01/2019 - 09/2010
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018 - 10/2009
2
Lymphocytosis
03/2017 - 02/2014
2
Leukemia
12/2012 - 12/2007
2
Polycythemia Vera
06/2009 - 04/2006
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2006 - 01/2003
1
Trisomy (Trisomies)
09/2016
1
Ataxia Telangiectasia (Louis Bar Syndrome)
08/2015
1
Infections
05/2012
1
Viremia
05/2012
1
Primary Myelofibrosis (Myelosclerosis)
06/2009
1
BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
06/2009
1
Paraproteinemias (Monoclonal Gammopathy)
01/2009
1
Polycythemia (Erythrocytosis)
06/2008
1
Hematologic Neoplasms (Hematological Malignancy)
05/2008
1
Refractory Anemia
07/2006
1
Genetic Translocation (Chromosomal Translocation)
09/2005
1
Myeloproliferative Disorders (Myeloproliferative Disorder)
09/2005
1
Residual Neoplasm
05/2005
Drug/Important Bio-Agent (IBA)
9
Immunoglobulins (Immunoglobulin)
IBA
11/2021 - 01/2009
5
fludarabine
IBA
12/2019 - 06/2011
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2019 - 06/2011
5
Biological Products
IBA
01/2019 - 02/2003
3
Biomarkers (Surrogate Marker)
IBA
04/2022 - 10/2016
3
Rituximab (Mabthera)
FDA Link
12/2019 - 05/2012
3
Antigens
IBA
01/2019 - 04/2016
3
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 06/2005
2
Antioxidants
IBA
08/2015 - 06/2005
2
Chlorambucil (Leukeran)
FDA Link
12/2012 - 06/2011
2
Alemtuzumab (Campath)
FDA Link
05/2012 - 05/2005
2
Proteins (Proteins, Gene)
FDA Link
05/2008 - 12/2005
1
Complementarity Determining Regions (Complementarity Determining Region)
IBA
01/2019
1
olaparib
IBA
01/2018
1
RNA (Ribonucleic Acid)
IBA
01/2018
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2018
1
B-Cell Antigen Receptors (B Cell Antigen Receptors)
IBA
09/2016
1
Chromatin
IBA
01/2016
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
11/2015
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
08/2015
1
Itraconazole (Sporanox)
FDA Link
Generic
05/2012
1
Valganciclovir
FDA Link
05/2012
1
Acyclovir (Aciclovir)
FDA Link
Generic
05/2012
1
Methylprednisolone
FDA Link
Generic
05/2012
1
Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)
FDA Link
Generic
05/2012
1
Alkylating Agents
IBA
03/2012
1
purine
IBA
03/2012
1
Hemoglobins (Hemoglobin)
IBA
09/2010
1
Histone Methyltransferases
IBA
08/2010
1
MicroRNAs (MicroRNA)
IBA
10/2009
1
N 30
IBA
06/2009
1
Erythropoietin
FDA Link
06/2008
1
endothelial PAS domain-containing protein 1
IBA
06/2008
1
Oxygen (Dioxygen)
IBA
06/2008
1
Phosphotransferases (Kinase)
IBA
05/2008
1
Tyrosine (L-Tyrosine)
FDA Link
05/2008
1
RNA Precursors (Precursor, mRNA)
IBA
05/2008
1
Pharmaceutical Preparations
IBA
12/2007
1
Interferons
IBA
07/2006
1
Heme (Haem)
IBA
07/2006
1
Imatinib Mesylate (Gleevec)
FDA Link
04/2006
1
Interferon-alpha (Interferon Alfa)
IBA
04/2006
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
09/2005
1
Uracil
IBA
06/2005
1
Enzymes
IBA
06/2005
1
Adenine
FDA Link
Generic
06/2005
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
06/2003
1
Immunoglobulin M (IgM)
IBA
02/2003
1
Immunoglobulin Variable Region
IBA
02/2003
Therapy/Procedure
5
Therapeutics
01/2018 - 01/2003
2
Drug Therapy (Chemotherapy)
05/2012 - 12/2007
1
Ligation
02/2003